The Long View

In the era of Big Data, research projects that focus on phenomena that unfold across decades have distinct benefits—and some drawbacks.

Written byKerry Grens
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

BACK OFF: A mother marmot with her pups makes an alarm call.© BEN HULSE
This spring, ecologist Dan Blumstein’s research team headed out to field sites in Colorado to study yellow-bellied marmots (Marmota flaviventris), large mountain rodents related to ground squirrels. The team’s observations will help determine how the animals are responding to a major population crash that occurred in 2011. “This year there was not a lot of snowpack, and that acts as insulation for animals underground,” says Blumstein, a professor at the University of California, Los Angeles. “It’s always, ‘Are there going to be any animals?’”

The precipitous drop in marmot numbers came as a bit of a surprise. For 40 years, marmot populations in the Upper East River Valley of Colorado had fluctuated—from 100 animals, to 60, to 30, and back up again. But during the decade preceding the crash, a decade of shorter-than-average winters, the marmot population had surged. “It tripled in size and got up to 300 animals. We were sort of overrun with marmots,” says Blumstein. Then, after an unusually long winter in 2011, the population plummeted. Blumstein says the marmot study highlights the value of long-term data sets spanning decades. “Had we quit after the first 40 years, we would have had a different perspective on what’s possible,” he says.

“Long-term data sets create a certain ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies